Skip to main content
. 2023 Nov 15;32(1):49–60. doi: 10.32604/or.2023.042383

Table 1. Signaling pathways activated by CD47 in cancer cells.

Signaling pathway Description Effects References
PI3K/Akt/mTOR CD47 overexpression activate PI3K/Akt/mTOR signaling pathway Promotes tumor cell survival, migration, and inhibits apoptosis [44,61]
NF-κB CD47 interacts with TSP-1, which is expressed on stromal cells in the TME, and activates downstream NF-κB pathway Promotes tumor cell survival, invasion, and angiogenesis while inhibiting immune cell function [62,63]
SIRPα CD47 interacts with SIRPα, inhibiting phagocytosis of cells expressing CD47 Allows cells to evade immune surveillance [50,60,64]
PI3K/Akt CD47 interacts with PI3K/Akt pathway Regulates cellular processes such as cell survival, proliferation, and migration [61,65]